The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | V | Various | |
| 2 | V10 | Therapeutic radiopharmaceuticals | |
| 3 | V10B | Pain palliation (bone seeking agents) | |
| 4 | V10BX | Various pain palliation radiopharmaceuticals | |
| 5 | V10BX02 | Samarium (153Sm) lexidronam |
| Active Ingredient | Description | |
|---|---|---|
| Samarium ¹⁵³Sm lexidronam |
Samarium has an affinity for skeletal tissue and concentrates in areas of bone turnover in intimate association with hydroxyapatite. It is indicated for the relief of bone pain in patients with multiple painful osteoblastic skeletal metastases which take up technetium (99mTc)-labelled biphosphonates on bone scan. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| QUADRAMET Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
